Our study analyzed the relationship of the SNPs at the IL-18-137 and -607 sites with the susceptibility to sporadic breast cancer, and a possible interaction of the IL-18 gene with menopause, BMI in Chinese Han women.
| INTRODUC TI ON
It is predicted that IL-18 gene promoter region SNP-137G/C and -607G/T can influence expression and activity of IL-18, respectively. 2 Arimitsu et al 3 found that the production capability of IL-18
by monocytes from volunteers with -137G/G genotype was significantly higher than that with -137G/C genotype. Research showed that IL-18 can suppress antitumor immunity in a programmed death-1 (PD-1)-dependent manner, PD-1 is a co-inhibitory receptor and one of the major checkpoints. 4 Furthermore, the association was verified between the 2 SNPs and the susceptibility to many cancers. [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] However, studies focus on the role of IL-18 polymorphisms on the risk of breast cancer remain controversial. To the best of our knowledge, only 3 studies have estimated the impact of IL-18 polymorphisms -137G/C and/or -607A/C on breast cancer susceptibility. [15] [16] [17] Khalili et al recruited 200 breast cancer patients and 206 healthy controls to examine the effect of -607A/C and -137G/C gene polymorphism of IL-18 on breast cancer risk. They found that CC homozygote of -137G/C polymorphism will reduce breast cancer risk, but IL-18 -607A/C polymorphism is not associated with the susceptibility to breast cancer. 15 Taheri et al recruited 72 patients with breast cancer and 93 healthy controls to investigate the association of IL-18 gene polymorphisms -607A/C with breast cancer in a sample of Iranian population. And no meaningful association was found. 16 Back et al recruited 154 breast cancer patients and 118 healthy controls to evaluated the association of -607A/C and -137G/C gene polymorphism with breast cancer risk.
Their result suggested that IL-18-607A/C and -137G/C polymorphism contribute to increase the breast cancer risk. 17 No study has taken the interaction between the 2 SNPs and body mass index 
| ME THODS

| Data acquisition
The study was approved by the Beijing meitan general hospital 
| Specimen processing
About 3 mL of EDTA-K2 anticoagulant fasting venous blood was collected. DNA was extracted from peripheral blood leukocytes using a TIANamp Blood DNA Kit (Tiangen Biotech Co., Ltd., Beijing, China).
The extracted DNA was stored at −80°C until use. 
| Statistical method
Pairwise comparison analysis was performed with the breast cancer, benign breast disease and healthy control groups to observe whether there was an association of the 2 selected SNP sites with disease susceptibility. Online analysis software (http://bioinfo.iconcologia.net/snpstats) and SPSS 16.0 (SPSS Inc., Chicago, IL, USA)
were used for statistical analysis. The SNP analysis included the following tests: Hardy-Weinberg equilibrium analysis; association strength analysis of the genotype frequency and allele frequency with the disease; linkage disequilibrium analysis; and haplotype analysis. The Chi-square test was used to compare univariate count data, and unconditional logistic regression analysis was used to compare multivariate count data. The odds ratio OR value and 95% confidence intervals (95% CI) were calculated to assess the association strength of the SNP with the risk of breast disease and lymph node metastasis in breast cancer.
Akaike information criterion (AIC) and Bayesian information criterion (BIC) were used to select the best SNP inheritance model. A P value <.05 was considered significant.
| RE SULTS
| Hardy-Weinberg equilibrium test
The Hardy-Weinberg equilibrium goodness of fit test for the -137G/C and -607G/T sites of the IL-18 gene was performed for the 3 groups, and the result is shown in Table 2 . In our recruited 3 groups, the frequencies of genetic polymorphisms were all in the Hardy-Weinberg equilibrium.
| Association strength analysis of the -137G/C and -607G/T genotypes and alleles with breast diseases
| Analysis comparison of the malignant and healthy groups
A case-control study with a healthy population serving as a control group was performed to observe the correlation of genotypes of 2 SNP sites and the allele frequency distribution with malignant breast tumors. The logistic regression analysis after adjusting the initial diagnosis age showed that -137 G/C genotype can decrease the risk of breast cancer (OR = 0.54, 95% CI: 0.31-0.93; P = .025) and that (Table 3 ).
TA B L E 1 General information of populations included in each group
| Analysis comparison of the benign and malignant groups
A case-control study with a benign breast disease population as (Table 4 ). In addition, no interactions between the 2 SNPs and menopause or BMI were found (Table 5) .
| Analysis of the benign and healthy groups
Healthy individuals were used as the control group to observe the correlation between the 2 SNPs and the risk of benign breast diseases. Logistic regression analysis showed that there was no association between the 2 SNPs and benign breast disease susceptibility.
| Analysis of the lymph node metastatic breast cancer group and the non-metastatic breast cancer group
According to lymph node metastasis condition, the breast cancer patients were divided into the lymph node metastasis group and the lymph node non-metastasis group to perform unconditional logistic regression analysis. The analysis results showed that there was no significant association between the 2 SNPs and the risk of lymph node metastasis.
The interaction analysis found that the IL-18-607 G/T gen- (Table 6 ). However, no interaction was found between the -137G/C site and menopause status or BMI. The odds ratios (OR) with their 95% confidence intervals (CI) were estimated by logistic regression models. The adjusted odds ratios (OR*) and P* were estimated by multiple logistic regression models, after adjusting age of first diagnosis. Best model according to the Akaike Information Criteria (AIC) and Bayesian Information Criteria (BIC).
TA B L E 3 -607G/T and -137G/C association with breast cancer susceptibility (Malignant vs Healthy)
TA B L E 2 Hardy-Weinberg equilibrium test -137G/C site (P value) -607G/T site (P value)
Benign group (n = 150) .42 .14 Malignant group (n = 178) . 21 .37
Healthy group (n = 160) 1 1
| Analysis of linkage disequilibrium
To perform haplotype analysis, we first performed a pairwise linkage disequilibrium test among the 3 established groups. vs non-metastasis group of the malignant breast tumor patients (.124). These data indicated that both of the SNP sites, -137G/C and -607G/T, had no linkage disequilibrium in each population group included in this study.
| Comparison of histochemical staining groups
According to the results of the histochemical staining, the patients in the malignant group were divided into the following 4 groups :
luminal A type group, luminal B type group, Her-2 overexpression type group and Basal-Like type group. Pairwise comparison analysis was conducted. However, no significant results were found.
| D ISCUSS I ON
Breast cancer is one of the major threats to female health, worldwide. Currently, breast cancer is treated with surgery, followed by chemotherapy or radiation therapy, or both. However, a substantial proportion of breast cancer patients might have a risk for recurrence and metastasis. 18 Therefore searching for new and potential strategies for risk prediction and treatment of breast cancer remains necessary. Immunotherapy as an attractive and promising approach, has gradually become the focus of many studies.
18-21
Interleukin-18 was first discovered as an inducible factor of interferon-gamma. 22 Research showed that IL-18 can suppress antitumor immunity in a PD-1-dependent manner, PD-1 is a co-inhibitory TA B L E 4 -607G/T and -137G/C association with breast cancer susceptibility (Benign vs Malignant) The odds ratios (OR) with their 95% confidence intervals (CI) were estimated by logistic regression models. The adjusted odds ratios (OR*) and P* were estimated by multiple logistic regression models, after adjusting age of first diagnosis. Best model according to the Akaike Information Criteria (AIC) and Bayesian Information Criteria (BIC).
TA B L E 5
Interaction analysis between single nucleotide polymorphisms (SNPs) and menopausal state The odds ratios (OR) with their 95% confidence intervals (CI) were estimated by logistic regression models.
receptor and one of the major checkpoints. 4 Furthermore, the association was verified between the 2 SNPs and the susceptibility to many cancers, including hepatocellular carcinoma, 5 non-small-cell lung cancer, 6 papillary thyroid carcinoma, 7 chronic leukemia, 23 oral squamous cell carcinoma. 24 Although there have been reports on the association analysis of the IL-18 -137, and -607 sites with susceptibility to breast cancer, but the conclusions are not consistent. [15] [16] [17] These controversial results may due to the genetic differences between various populations. However, there is no report on the association between IL-18 and susceptibility to breast cancer according to a stratified analysis of menopause, BMI and other factors.
In the present study, when the malignant group was compared with the healthy control group, the result showed that IL-18 -137G/C genotype was a protective factor for breast cancer. But, the comparative analysis between the benign group and the malignant group showed that IL-18 -137G/C genotype was a risk factor for benign group. So, -137 G/C genotype may be a protective factor for healthy group, but a risk factor for benign group. One of the possible explanations for the controversial effect of IL-18 -137 G/C polymorphism in breast cancer susceptibility and clinical progression is that IL-18 has dual effects on cancer development and progression. 25, 26 When the benign group was compared with the healthy control group, the result showed that there was no significant association between genetic polymorphisms of IL-18 -607G/T and -137G/C and benign breast diseases susceptibility.
When the lymph node metastasis breast cancer group was compared with the non-metastasis breast cancer group, result showed that IL-18-607 G/T genotype have an interaction with menopausal and BMI. IL-18-607 G/T genotype can increase the risk of lymph node metastasis for the postmenopausal and overweight or obese subjects. This means that the causes of breast cancer may include heredity, endocrine, and external environment.
The results of the linkage disequilibrium test showed that the -137G/C and -607G/T sites had no linkage disequilibrium in the present study.
In sumary, IL-18-137 G/C genotype may be a protective factor for healthy group, but a risk factor for benign group. IL-18-607 G/T genotype have an interaction with menopausal and BMI. The synergetic effect can further increase the risk of lymph node metastasis for breast cancer patients.
Our results and conclusions should be verified because of several limitations. Firstly, the present study just focused on Chinese
Han women. Secondly, the case number of each study group was limited. Thirdly, the association was not investigated between the 2 IL-18 SNPs and IL-18 serum levels in our study, since serum IL-18 levels may be affected by various factors, some of these may mask the gene polymorphism effects. Fourthly, we just controlled age, menopausal and BMI, however, other possible confounding factors (living habits, smoking, and alcohol consumption) may cause some bias. BMI, body mass index. The odds ratios (OR) with their 95% confidence intervals (CI) were estimated by logistic regression models.
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